Pelthos Therapeutics Inc.

PTHS
$27.00 (- $0.16 - 0.59%)
Last updated: 2026-07-10 20:16 UTC
PTHS Metrics
Exchange
🇺🇸 NYSE XASE
NYSE Mkt LLCUnited StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS1711262048
CUSIP171126204
Market Price27.0
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-17.82
Market Cap$81.8M
Book Value18.85
Price to Book1.406
BetaN/A
52w High54.29
52w Low6.01
Next Earnings DateN/A

Pelthos Therapeutics Inc. trades under ticker PTHS on NYSE as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US1711262048, CUSIP 171126204.

About the Company
Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older. It also provides NITRICIL, a proprietary nitric oxide-based technology platform. The company was formerly known as Channel Therapeutics Corporation and changed its name to Pelthos Therapeutics Inc. in July 2025. Pelthos Therapeutics Inc. was founded in 2002 and is based in Durham, North Carolina.
Price History